135 related articles for article (PubMed ID: 21142090)
41. Hyaluronic acid in Pluronic F-127/F-108 hydrogels for postoperative pain in arthroplasties: Influence on physico-chemical properties and structural requirements for sustained drug-release.
Nascimento MHM; Franco MKKD; Yokaichyia F; de Paula E; Lombello CB; de Araujo DR
Int J Biol Macromol; 2018 May; 111():1245-1254. PubMed ID: 29339288
[TBL] [Abstract][Full Text] [Related]
42. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function.
Hirakura T; Yasugi K; Nemoto T; Sato M; Shimoboji T; Aso Y; Morimoto N; Akiyoshi K
J Control Release; 2010 Mar; 142(3):483-9. PubMed ID: 19951730
[TBL] [Abstract][Full Text] [Related]
43. Temperature-responsive and biodegradable PVA:PVP k30:poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH).
Taheri A; Atyabi F; Dinarvnd R
J Pediatr Endocrinol Metab; 2011; 24(3-4):175-9. PubMed ID: 21648286
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
45. Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.
Yu Z; Guo F; Guo Y; Zhang Z; Wu F; Luo X
PLoS One; 2017; 12(3):e0173949. PubMed ID: 28350799
[TBL] [Abstract][Full Text] [Related]
46. Effect of temporally controlled release of dexamethasone on in vivo chondrogenic differentiation of mesenchymal stromal cells.
Bae SE; Choi DH; Han DK; Park K
J Control Release; 2010 Apr; 143(1):23-30. PubMed ID: 20056124
[TBL] [Abstract][Full Text] [Related]
47. Influence of the concentrations of hyaluronic acid on the properties and biocompatibility of Cs-Gel-HA membranes.
Liu H; Yin Y; Yao K; Ma D; Cui L; Cao Y
Biomaterials; 2004 Aug; 25(17):3523-30. PubMed ID: 15020126
[TBL] [Abstract][Full Text] [Related]
48. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin.
Hahn SK; Kim JS; Shimobouji T
J Biomed Mater Res A; 2007 Mar; 80(4):916-24. PubMed ID: 17072846
[TBL] [Abstract][Full Text] [Related]
49. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent.
Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H
Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144
[TBL] [Abstract][Full Text] [Related]
50. Characterization of thermosensitive chitosan-based hydrogels by rheology and electron paramagnetic resonance spectroscopy.
Kempe S; Metz H; Bastrop M; Hvilsom A; Contri RV; Mäder K
Eur J Pharm Biopharm; 2008 Jan; 68(1):26-33. PubMed ID: 17870449
[TBL] [Abstract][Full Text] [Related]
51. Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine.
Lee KR; Kim EJ; Seo SW; Choi HK
Arch Pharm Res; 2008 Aug; 31(8):1023-8. PubMed ID: 18787792
[TBL] [Abstract][Full Text] [Related]
52. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
Abdeltawab H; Svirskis D; Sharma M
Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
[No Abstract] [Full Text] [Related]
53. Effect of a composite membrane of chitosan and poloxamer gel on postoperative adhesive interactions.
Vlahos A; Yu P; Lucas CE; Ledgerwood AM
Am Surg; 2001 Jan; 67(1):15-21. PubMed ID: 11206889
[TBL] [Abstract][Full Text] [Related]
54. Comparison of poloxamer- and chitosan-based thermally sensitive gels for the treatment of vaginal mucositis.
Rossi S; Ferrari F; Bonferoni MC; Sandri G; Faccendini A; Puccio A; Caramella C
Drug Dev Ind Pharm; 2014 Mar; 40(3):352-60. PubMed ID: 23600650
[TBL] [Abstract][Full Text] [Related]
55. Amphiphilic hyaluronic acid derivatives toward the design of micelles for the sustained delivery of hydrophobic drugs.
Mayol L; Biondi M; Russo L; Malle BM; Schwach-Abdellaoui K; Borzacchiello A
Carbohydr Polym; 2014 Feb; 102():110-6. PubMed ID: 24507262
[TBL] [Abstract][Full Text] [Related]
56. Potential of fortified fibrin/hyaluronic acid composite gel as a cell delivery vehicle for chondrocytes.
Park SH; Cui JH; Park SR; Min BH
Artif Organs; 2009 Jun; 33(6):439-47. PubMed ID: 19473139
[TBL] [Abstract][Full Text] [Related]
57. A methacrylated hyaluronic acid network reinforced Pluronic F-127 gel for treatment of bacterial keratitis.
Wang A; Dong L; Guo Z; Sun W; Mi S
Biomed Mater; 2022 May; 17(4):. PubMed ID: 35545060
[TBL] [Abstract][Full Text] [Related]
58. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels.
Chun KW; Lee JB; Kim SH; Park TG
Biomaterials; 2005 Jun; 26(16):3319-26. PubMed ID: 15603827
[TBL] [Abstract][Full Text] [Related]
59. Controlled release of vancomycin from poloxamer 407 gels.
Veyries ML; Couarraze G; Geiger S; Agnely F; Massias L; Kunzli B; Faurisson F; Rouveix B
Int J Pharm; 1999 Dec; 192(2):183-93. PubMed ID: 10567749
[TBL] [Abstract][Full Text] [Related]
60. Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine.
Anirudhan TS; Nair SS; Nair AS
Carbohydr Polym; 2016 Nov; 152():687-698. PubMed ID: 27516320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
